Galmed Pharmaceuticals : Consolidated Financial Statements - Form 6-K -November 22, 2023 at 04:10 pm EST
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private...
Source: marketscreener.com
📰 Open Label Part News
Open Label Part News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Open Label Part. Real-time updates on events, politics, business and more.
Galmed Pharmaceuticals Reports First Quarter 2022 Financial Results
/PRNewswire/ —Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic, fibrosis...
Hebrew University Galmed Pharmaceuticals Ltd Galmed Pharmaceuticals Open Label Part Armor Study First Quarter
Source: prnewswire.com
Galmed updates business and clinical development strategy to better leverage Aramchol's anti-fibrotic effects
Recent data reinforce the anti-fibrotic activity of Aramchol previously observed in a wide range of pre-clinical models, in addition to the known effects in...
Hebrew University Allen Baharaff Aramchol Meglumine Galmed Pharmaceuticals Ltd Prnewswire Galmed Pharmaceuticals Ltd Open Label Part
Source: prnewswire.com
Galmed reports interim results from the Open-Label part of the ARMOR study with Aramchol showing robust fibrosis improvement across multimodality histological assessment
/PRNewswire/ -- Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and...
United States Hebrew University Allen Baharaff Galmed Pharmaceuticals Ltd Artificial Intelligence Galmed Pharmaceuticals
Source: prnewswire.com
Galmed Announces Positive Results from First 16 Patients in Open-Label Part of ARMOR Study
/PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and...
United States Hebrew University Allen Baharaff Toll International Galmed Pharmaceuticals Ltd Prnewswire Galmed Pharmaceuticals Ltd
Source: prnewswire.com